electroCore (NASDAQ:ECOR) had its price objective dropped by analysts at Cantor Fitzgerald from $9.00 to $2.00 in a research report issued on Thursday, The Fly reports. The firm currently has a “neutral” rating on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 26.58% from the company’s current price.
Several other brokerages have also recently issued reports on ECOR. Zacks Investment Research cut electroCore from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. ValuEngine upgraded electroCore from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st. Evercore ISI restated a “buy” rating and issued a $9.00 price target on shares of electroCore in a research report on Wednesday. BTIG Research restated a “hold” rating on shares of electroCore in a research report on Wednesday, August 14th. Finally, Noble Financial restated a “buy” rating and issued a $11.00 price target on shares of electroCore in a research report on Thursday, August 15th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $6.95.
Shares of ECOR stock opened at $1.58 on Thursday. electroCore has a 52-week low of $1.23 and a 52-week high of $10.24. The stock’s 50-day moving average price is $1.95 and its 200 day moving average price is $2.42. The company has a debt-to-equity ratio of 0.04, a quick ratio of 5.93 and a current ratio of 6.63.
Several large investors have recently made changes to their positions in the company. Brighton Jones LLC boosted its stake in shares of electroCore by 15.1% during the 3rd quarter. Brighton Jones LLC now owns 52,340 shares of the company’s stock worth $115,000 after acquiring an additional 6,869 shares in the last quarter. Valeo Financial Advisors LLC boosted its stake in shares of electroCore by 101.6% during the 2nd quarter. Valeo Financial Advisors LLC now owns 26,000 shares of the company’s stock worth $52,000 after acquiring an additional 13,100 shares in the last quarter. Rockefeller Capital Management L.P. purchased a new stake in shares of electroCore during the 2nd quarter worth approximately $28,000. Bfsg LLC boosted its stake in shares of electroCore by 34.6% during the 3rd quarter. Bfsg LLC now owns 70,000 shares of the company’s stock worth $153,000 after acquiring an additional 18,000 shares in the last quarter. Finally, BlackRock Inc. boosted its stake in shares of electroCore by 3.7% during the 2nd quarter. BlackRock Inc. now owns 575,248 shares of the company’s stock worth $1,150,000 after acquiring an additional 20,536 shares in the last quarter. 9.91% of the stock is currently owned by institutional investors and hedge funds.
electroCore Company Profile
electroCore, Inc, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Featured Article: What is a Real Estate Investment Trust (REIT)?
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.